Phase III Clinical Trial of rhTNK-tPA in Treating Acute Ischemic Stroke With Extended Time Window.

Clinical trial NCT07201688 · RECRUITING

Trial details

NCT number: NCT07201688
Sponsor: CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Ischemic Stroke

Start date: 2025-11-30
Primary completion: 2027-09-30
Enrollment: 890

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.